ELIQUIS
NDC 0003-1028, apixaban, tablet, for suspension, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-1028
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202155
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-1028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APIXABAN.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-1028-12 | 00003102812 | 28 PACKET in 1 CARTON (0003-1028-12) / 4 TABLET, FOR SUSPENSION in 1 PACKET |
| 0003-1028-28 | 00003102828 | 28 PACKET in 1 CARTON (0003-1028-28) / 1 TABLET, FOR SUSPENSION in 1 PACKET |
| 0003-1028-84 | 00003102884 | 28 PACKET in 1 CARTON (0003-1028-84) / 3 TABLET, FOR SUSPENSION in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
- 2749695{84 (apixaban 0.5 MG Tablet for Oral Suspension [Eliquis]) } Pack [Eliquis 1.5 MG Dose Pack] (BPCK)
- 2749698{112 (apixaban 0.5 MG Tablet for Oral Suspension [Eliquis]) } Pack [Eliquis 2 MG Dose Pack] (BPCK)
- 2749700{28 (apixaban 0.5 MG Tablet for Oral Suspension [Eliquis]) } Pack [Eliquis 0.5 MG Dose Pack] (BPCK)
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0003-1028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-1028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-1028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.